[go: up one dir, main page]

TW200716226A - Compositions comprising actinidia and methods of use thereof - Google Patents

Compositions comprising actinidia and methods of use thereof

Info

Publication number
TW200716226A
TW200716226A TW095106341A TW95106341A TW200716226A TW 200716226 A TW200716226 A TW 200716226A TW 095106341 A TW095106341 A TW 095106341A TW 95106341 A TW95106341 A TW 95106341A TW 200716226 A TW200716226 A TW 200716226A
Authority
TW
Taiwan
Prior art keywords
actinidia
compositions
methods
disclosed
preparations
Prior art date
Application number
TW095106341A
Other languages
Chinese (zh)
Other versions
TWI385007B (en
Inventor
Julianne Lindemann
George E Stagnitti
Robert H Driver
Mark A Braman
Nancy E Fogg-Johnson
Sunyoung Kim
Eun-Jin Park
Bongcheol Kim
Mirim Jin
Hyung-Jin Jung
Sung-Seup Shin
Jin-Hwan Oh
Hwa-Jun Lee
Hyang Jeon
Original Assignee
Efficas Inc
Pangenomics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efficas Inc, Pangenomics Co Ltd filed Critical Efficas Inc
Publication of TW200716226A publication Critical patent/TW200716226A/en
Application granted granted Critical
Publication of TWI385007B publication Critical patent/TWI385007B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Disclosed are novel preparations of Actinidia, and particularly species of hardy kiwifruit, as well as compositions comprising the same. Also disclosed is the use of these preparations of Actinidia to prevent and/or treat a variety of diseases in which regulation of the immune response is effective, including both allergic and non-allergic inflammatory disease, viral infection, and cancer. Methods related to making and using these compositions are also described.
TW095106341A 2005-02-25 2006-02-24 Composition containing kiwifruit (Actinidia) and method of use thereof TWI385007B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65683905P 2005-02-25 2005-02-25
US65683805P 2005-02-25 2005-02-25

Publications (2)

Publication Number Publication Date
TW200716226A true TW200716226A (en) 2007-05-01
TWI385007B TWI385007B (en) 2013-02-11

Family

ID=36941647

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095106341A TWI385007B (en) 2005-02-25 2006-02-24 Composition containing kiwifruit (Actinidia) and method of use thereof

Country Status (8)

Country Link
EP (1) EP1858535A4 (en)
JP (1) JP2008531584A (en)
AU (1) AU2006218875B2 (en)
BR (1) BRPI0608042A2 (en)
MX (1) MX2007010408A (en)
RU (1) RU2423139C2 (en)
TW (1) TWI385007B (en)
WO (1) WO2006093793A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080175888A1 (en) * 2005-02-25 2008-07-24 Julie Lindemann Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
DE102006055210A1 (en) * 2006-11-21 2008-05-29 Ionescu, John G., Dr. Dietary food with increased free radical binding effect
KR101141182B1 (en) 2009-05-12 2012-05-02 재단법인 제주테크노파크 Composition for Anti-inflammation
US9352008B2 (en) 2009-08-12 2016-05-31 Melaleuca, Inc. Dietary supplements and methods for treating pain and inflammation
JP4750202B2 (en) * 2009-10-16 2011-08-17 株式会社 藍匠 Method for producing health supplements using Sarnashi
CN102724884A (en) * 2009-12-29 2012-10-10 雀巢产品技术援助有限公司 Nutritional composition comprising docosahexaenoic acid containing fruit flakes
JP5688233B2 (en) * 2010-04-23 2015-03-25 ポーラ化成工業株式会社 TARC production inhibitor
JP6179840B2 (en) * 2011-11-30 2017-08-16 国立大学法人 岡山大学 Highly polar organic solvent extract from Sarnashi and its utilization
JP6242669B2 (en) * 2013-11-27 2017-12-06 日本メナード化粧品株式会社 Hyaluronic acid production promoter containing a sarnashi extract
CN105410588B (en) * 2015-11-06 2018-05-08 四川兴食尚科技有限公司 A kind of Kiwi berry effervescent tablet and its preparation process
EP3797297A1 (en) * 2018-05-22 2021-03-31 N.V. Nutricia Biomarkers for improving nutrion for infants at risk

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242814A (en) * 1989-10-10 1993-09-07 Eli Lilly And Company Polyether antibiotic
SK283342B6 (en) * 1996-01-23 2003-06-03 Icn Pharmaceuticals Use of ribavirin for preparation of pharmaceutical composition
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
DE19758090B4 (en) * 1997-12-18 2008-10-16 Maria Endres Composition and its use in cosmetics and medicine
JP2002302458A (en) * 2000-12-26 2002-10-18 Takeda Chem Ind Ltd Combined medicine
DE60119699T2 (en) * 2001-03-29 2007-04-26 Council Of Scientific And Industrial Research PROCESS FOR PRODUCING FRUIT WINE FROM BERRIES OF HIMALAYA
US6811796B2 (en) * 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
US20040022914A1 (en) * 2002-06-07 2004-02-05 Allen Ann De Wees Novel sweetener compositions and methods of use
KR100615389B1 (en) * 2002-08-23 2006-08-25 (주)헬릭서 Health food comprising the extract of Actinidia arguta and related species for the prevention and improvement of allergic disease and non-allergic inflammatory disease

Also Published As

Publication number Publication date
JP2008531584A (en) 2008-08-14
AU2006218875B2 (en) 2012-08-09
EP1858535A2 (en) 2007-11-28
AU2006218875A1 (en) 2006-09-08
WO2006093793A3 (en) 2006-12-07
RU2423139C2 (en) 2011-07-10
BRPI0608042A2 (en) 2009-11-03
EP1858535A4 (en) 2012-05-02
RU2007135365A (en) 2009-03-27
TWI385007B (en) 2013-02-11
WO2006093793A8 (en) 2008-03-27
WO2006093793A2 (en) 2006-09-08
MX2007010408A (en) 2008-03-25

Similar Documents

Publication Publication Date Title
WO2007054279A8 (en) Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions
NO20016159D0 (en) Serine proteinases from fish and their pharmaceutical and cosmetic uses
PL1881823T3 (en) COMPOSITIONS AND METHODS OF EYE DISEASES TREATMENT
SG151315A1 (en) Human glp-1 mimetibodies, compositions, methods and uses
HRP20060254A2 (en) Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
TW200509892A (en) Novel aminobenzophenone compounds
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
EP2329835B8 (en) Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease
NO20092639L (en) 4-Phenyl-6- (2,2,2-trifluoro-1-phenylethoxy) pyrimidine-based compounds and uses thereof
WO2004092215A3 (en) Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
ITMI20041550A1 (en) USE OF PROBIOTIC BACTERIA FOR THE PREPARATION OF TOPICAL COMPOSITIONS FOR THE PROTECTION OF THE EPIDERMIS
WO2005081687A3 (en) Human hinge core mimetibodies, compositions, methods and uses
WO2005051914A8 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
TW200716226A (en) Compositions comprising actinidia and methods of use thereof
UA90698C2 (en) Triazole substituted aminobenzophenone compounds
TW200508246A (en) Anti-dengue virus antibodies, compositions, methods and uses
WO2004026260A3 (en) Prophylactic and therapeutic hiv aptamers
WO2010052575A3 (en) Ngna compositions and methods of use
WO2006057945A3 (en) 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
TW200716152A (en) Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture
WO2007059931A8 (en) New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions
ATE524488T1 (en) LYSOBACTINAMIDE
WO2005034857A3 (en) Methods and compositions comprising diamines as new anti-tubercular therapeutics
TW200716616A (en) Modulators of CCR-5 activity
TW200726763A (en) Novel compound

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees